I received a PM but as a new user I can not respond to PM yet. So thought others may want this info also.
I am not a doctor. I grew up a Respiratory Therapist...then obtained my Nursing degree. I have been working as an ECMO Specialist for most of the last 18 years. I currently own a company called ECMO Advantage. We provide ECMO consulting, ECMO Staffing, ECMO Specialist Training Programs, ECMO Transport, and ECMO Equipment rental. I provide that as a method of hopefully establishing some level of expertise in ECMO...not as an advertisement.
ECMO outcomes are very disease specific. And as I mentioned in the post...the patient must be viable. ECMO does not regenerate tisse/organs etc. If the damage is done...it won't be reversed. So of course there is always the balance between putting a patient on EARLY that some will argue didn't need ECMO vs the opposite senario where it's a last ditch effort and there isn't a viable patient. So the goal would be for appropriate ECMO use to reside somewhere in the middle. Patient selection is important for appropriate use of this life support modality.
There are several recent controversial ECMO outcome reports of interest. The CESAR Trial was reported out of Europe about 2 years ago now. It was specific to Adult Respiratory Failure patients.
ELSO also has their H1N1 database outcomes available to the public on their web site.
The ELSO database is probably the most comprehensive place to find reliable outcome information regarding ECMO patients. At least for survival. They do not have good "quality of life" information. CESAR did address quality of life.
Cardiac indications...especially post-op cardiac surgery and "E-CPR" (utilizing ECMO as CPR modality) have the poorest outcomes. But CPR in general also has relatively poor outcomes.
ECMO for Cardiac Bridge to Transplant, Bridge to Destination Therapy, and Bridge to Decision have better overall outcomes. This population may be great candidates for ECMO Transport and involve the EMT community more.
Unfortunately, good literature that definitively answer the questions related to ECMO are rare. and it's very difficult to design and carry out such studies. So we are often stuck with case reports, small volume studies, antidotal reports, and the rare reports such as CESAR Trial and the ELSO H1N1 data to pull from. So I am certainly not going to try to convince you that everyone should run out and provide ECMO support. But I would encourage you to continue to seek out the answers and remain open to the possibilities that ECMO may be a good choice for the patients you provide service to. There are close to 50,000 patients in the ELSO data base. I'm pretty sure the majority of them and/or their families are very glad ECMO was there to serve them.
I can tell you that ECMO, and especially Adult ECMO, is becoming more and more popular. Our greatest growth area is assisting Institutions establish Adult ECMO programs. In addition, we are getting more and more requests to provide Adult ECMO Transports from smaller rural hospitals in to major institutions that provide transplantation services or at least to hospitals that have established ECMO programs.
And with the advances we are seeing in technology, i.e. the Cardiohelp, Alung, NovaLung, etc...I do believe in the next few years we will see extracorporeal support expand to the point that it is available in most ICU's in the United States. Ok...so with that statement I probably just completely discredited myself.
But store that thought away in the back of your mind and pull it back out 10 years from now. Will be interesting to see if I am correct.